The underlying mechanisms of tau hyperphosphorylation in epilepsy involve alteration of tau kinases like glycogen synthase kinase-3β (GSK-3β) and cyclin-dependent kinase 5 (CDK5); overactivation of both has been detected in resected tissue from refractory patients with epilepsy [20]. Here, GSK3B is linked to epilepsy.